Skip to main content
HAPN · Why this verdict

Why Happen (HAPN) is rated HOLD

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictHOLD
Overall score6.6/10
ConfidenceHIGH
MacroRISK_OFF
TrendMatrix Research · core thesis

Engine thesis — one sentence

Happen is a regional bank at a forward P/E of 5.9x with the price 51.3% below the $21.32 analyst target and an unbroken run of earnings beats (average +17%), but the stock is in a confirmed downtrend, insiders are selling and earnings are due in 4 days.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

The shares trade at a forward P/E of 5.9x and the $14.09 price is 51.3% below the $21.32 analyst target, so the market is pricing in substantial risk.

→Stable
Upside pct
Expectation
Price should move toward the $21.32 target as earnings keep growing over 12 months.

CounterAnalyst coverage is light and a 74% implied upside with a falling stock suggests the market doubts the targets.

EPS beat estimates in 3 of the last 4 quarters with none missed, for an average surprise of +17.15%, including $0.50 versus $0.42 in July.

↑Improving
Avg surprise pct
Expectation
EPS should meet or beat the estimate at the 2026-10-28 report and stay at or above $0.45 per quarter.

CounterEstimates were low and the January report was only inline; with earnings in 4 days the stock sits in a downtrend, so a beat may already be expected.

Cash conversion is excellent, with free cash flow at 618% of net income and a Piotroski F-Score of 7/9, supporting a quality score of 6.6.

→Stable
Quality breakdown
Expectation
Free cash flow should stay above net income and quality should stay above 6.0 over the next 12 months.

CounterFor a bank, operating cash flow includes loan-sale and deposit timing, so a 618% ratio is not a reliable measure of earnings quality.

The stock trades below its 200-day average, which is falling 3.3% per 30 days, with falling on-balance volume and a death cross, a confirmed downtrend.

↓Deteriorating
Momentum breakdown
Expectation
Price should hold above the $13.46 stop level and reclaim its 200-day average over the next two quarters.

CounterBollinger and support scores of 9.5 and 8.9 suggest the stock is near support, and a strong earnings report could reverse the trend.

Insiders sold about $3.7M of stock (0.229% of market cap) in 9 sales over 90 days with no buying, which weighs on the otherwise strong earnings case.

→Stable
Insider breakdown
Expectation
Net insider selling should fall below 0.1% of market cap over the next two quarters.

CounterA sale of 0.229% of market cap is moderate, and institutions are adding shares according to the holder-change score of 7.1.

Per-dimension breakdown

Value

9.6/10data confidence 100%
ComponentSub-score
P/E9.3
P/S9.5
EV/EBITDA10.0
Fwd P/E9.8
PEG10.0
Analyst target9.0
  • ▸Forward P/E: 6.1x
  • ▸PEG: 0.02
  • ▸Attractively valued

Quality

6.6/10data confidence 100%
ComponentSub-score
ROE4.4
ROA0.9
Gross margin4.4
Op margin8.6
Net margin7.0
Current ratio9.5
FCF quality10.0
Moat7.0
Piotroski F7.8
  • ▸Excellent cash conversion: 618% FCF/NI
  • ▸Strong Piotroski F-Score: 7/9

Growth

7.0/10data confidence 67%
ComponentSub-score
Rev growth4.1
EPS growth10.0

Momentum

4.5/10data confidence 100%
ComponentSub-score
RSI3.5
MACD6.9
OBV5.6
MA position1.0
Volume5.3
  • ▸Below 200-MA, MA slope -3.8%/30d — confirmed downtrend

Sentiment

6.7/10data confidence 100%
ComponentSub-score
LLM sentiment5.6
Analyst rating5.0
Price target9.9
  • ▸Analyst upside: 71%

Insider

4.8/10data confidence 100%
ComponentSub-score
materiality3.0
insider conviction2.0
holder change7.1
notable moves7.0
  • ▸Notable insider selling — $3,722,531 (0.225% of mkt cap)

Peer rank

5.3/10data confidence 80%
ComponentSub-score
value rank9.2
quality rank3.9
growth rank3.2
  • ▸Attractive P/E vs peers

Technical

5.8/10data confidence 100%
ComponentSub-score
bollinger7.0
support resistance7.1
52w position3.2

Risk (lower is worse)

5.9/10data confidence 100%
ComponentSub-score
short interest6.2
days to cover6.7
volatility3.1
put call10.0
implied vol1.3
beta3.7
debt equity10.0
  • ▸High IV: 72%
  • ▸Concentration risks: 1 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)

Catalyst

7.8/10data confidence 100%
ComponentSub-score
erm3.5
earnings history10.0
surprise avg9.8
news activity8.0
  • ▸Strong earnings: 3B/0M

How the verdict was assembled

Engine trigger

Maintain position. Not compelling to add more.

Engine technical detail
verdict_path: L4:PATH_F_HOLD
Passed (5)
  • ASYMMETRY:6.5>=1.5
  • NEWS_BOOST:EARNINGS:0.60
  • EARNINGS_PROXIMITY:NO_DATE
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
  • MOMENTUM:4.5<4.5
  • DEATH_CROSS:HARD_BLOCK
Warning (2)
  • INSIDER:0.23%=MODERATE
  • 8K_FLAG:3.01
Reward-to-Risk
6.49
Upside
+48.6%
Downside
7.5%
Sizing output
AVOID

Setup— — No clear chart pattern; technical signals are mixed

EdgeInst Constrain — Small cap ($1.7B) below institutional reach

SuitabilityAggressive — Beta 1.89>1.3, MCap $1.7B<$5B

Investment implication

None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: ASYMMETRY:6.5>=1.5. Top dim: Value at 9.6; weakest: Momentum at 4.5. No conviction either direction.

The strongest dimensions are Value at 9.6, Catalyst at 7.8, and Growth at 7.0; the weakest are Momentum at 4.5, Insider at 4.8, and Peer rank at 5.3. The V9 engine flagged 2 failed gates with 2 warnings, producing an asymmetric reward-to-risk of 6.49 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Cheap Valuation Analyst Upside

    Trip ifAnalyst target falls below $16.90, cutting upside to less than 20%.

  • P2Consistent Earnings Beats

    Trip ifEPS surprise stays below 0% for 2 consecutive quarters.

  • P3Excellent Cash Conversion

    Trip ifQuality score falls below 5.0 from the current 6.6.

  • P4Confirmed Downtrend Price

    Trip ifPrice falls below $13.46, the stop level, from the current $14.09.

  • P5Insider Selling

    Trip ifInsider selling exceeds 0.5% of market cap over 90 days from the current 0.23%.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home › Stocks › HAPN › Why this verdict